BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
0.3985
+0.0080 (2.05%)
At close: Jul 2, 2025, 4:00 PM
0.3977
-0.0008 (-0.20%)
After-hours: Jul 2, 2025, 5:26 PM EDT
BioAtla Market Cap
BioAtla has a market cap or net worth of $23.28 million as of July 2, 2025. Its market cap has decreased by -69.18% in one year.
Market Cap
23.28M
Enterprise Value
-8.58M
1-Year Change
-69.18%
Ranking
Category
Stock Price
$0.40
Market Cap Chart
Since the IPO on December 16, 2020, BioAtla's market cap has decreased from $577.60M to $23.28M, a decrease of -95.97%. That is a compound annual growth rate of -50.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2025 | 22.81M | -33.50% |
| Dec 31, 2024 | 34.30M | -70.91% |
| Dec 29, 2023 | 117.92M | -69.81% |
| Dec 30, 2022 | 390.66M | -45.97% |
| Dec 31, 2021 | 723.09M | -36.84% |
| Dec 31, 2020 | 1.14B | 98.22% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 698.22B |
| Johnson & Johnson | 365.29B |
| AbbVie | 326.45B |
| Novo Nordisk | 304.96B |
| UnitedHealth Group | 281.59B |
| Abbott Laboratories | 235.90B |
| Novartis AG | 235.85B |
| AstraZeneca | 215.00B |